Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry.
Tello K, Yogeswaran A, Majeed RW, Kiely DG, Lawrie A, Brittain E, Annis JS, Olschewski H, Kovacs G, Hassoun PM, Balasubramanian A, Konswa Z, Sweatt AJ, Zamanian RT, Wilkins MR, Howard L, Arvanitaki A, Giannakoulas G, Cajigas HR, Frantz R, Williams PG, Frauendorf M, Marquardt K, Antoine T, Fuenderich M, Richter M, Grimminger F, Ghofrani HA, Wilhelm J, Seeger W; PVRI-GoDeep-Consortium Imad Al Ghouleh.
Tello K, et al. Among authors: olschewski h.
Chest. 2024 Aug 23:S0012-3692(24)05046-3. doi: 10.1016/j.chest.2024.08.016. Online ahead of print.
Chest. 2024.
PMID: 39182575